Additional Evidence That End-of-Treatment Fluorodeoxyglucose-Positron Emission Tomography Evaluation Is Necessary in Advanced Hodgkin Lymphoma

Affiliations

Comment

Charles Mesguich et al. J Clin Oncol. 2018.

. 2018 Jul 10;36(20):2124-2125.

doi: 10.1200/JCO.2018.78.6780. Epub 2018 May 23.

¹ Charles Mesguich, Krimo Bouabdallah, Noël Milpied, and Elif Hindié, Bordeaux University Hospital, Bordeaux, France.

No abstract available

Comment in

Reply to H.J.A. Adams et al and C. Mesguich et al.
Gallamini A, Viviani S, Pavoni C, Rambaldi A. Gallamini A, et al. J Clin Oncol. 2018 Jul 10;36(20):2125-2126. doi: 10.1200/JCO.2018.78.7762. Epub 2018 May 23. J Clin Oncol. 2018. PMID: 29791290 No abstract available.

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Gallamini A, Tarella C, Viviani S, Rossi A, Patti C, Mulé A, Picardi M, Romano A, Cantonetti M, La Nasa G, Trentin L, Bolis S, Rapezzi D, Battistini R, Gottardi D, Gavarotti P, Corradini P, Cimminiello M, Schiavotto C, Parvis G, Zanotti R, Gini G, Ferreri AJM, Viero P, Miglino M, Billio A, Avigdor A, Biggi A, Fallanca F, Ficola U, Gregianin M, Chiaravalloti A, Prosperini G, Bergesio F, Chauvie S, Pavoni C, Gianni AM, Rambaldi A. Gallamini A, et al. J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23. J Clin Oncol. 2018. PMID: 29360414 Clinical Trial.